Can kids quit their eczema drug? new trial aims to find out
NCT ID NCT06116526
Summary
This study is testing whether children aged 1-17 who have their atopic dermatitis (eczema) well-controlled with the drug dupilumab can safely reduce their dose or stop taking it altogether. Participants will be randomly assigned to either continue their standard dose, take a lower dose, or stop the medication, and researchers will monitor their skin condition and symptoms. The goal is to see if reducing medication is a feasible long-term option for managing eczema in children.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Johns Hopkins Univerisity
RECRUITINGBaltimore, Maryland, 21210, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.